Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 268
Growth YoY: +12.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,897)

clinicaltrialsPublishedShowing 1,001–1,050 of 1,965 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02460835	A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma	completed	N/A	77	University of Michigan Rogel Cancer CenterOTHER	1	Nov 15, 2023	clinicaltrials
NCT04229381	Resiliency Among Older Adults Receiving Lung Cancer Treatment(ROAR-LCT)	completed	N/A	18	Ohio State University Comprehensive Cancer CenterOTHER	1	Nov 15, 2023